Company Filing History:
Years Active: 2011-2014
Title: Innovations of Junbo Wang in Lipid Level Reduction
Introduction
Junbo Wang is a prominent inventor based in Shanghai, China. He has made significant contributions to the field of lipid level reduction through his innovative research and patented technologies. With a total of 3 patents, his work focuses on developing compounds and compositions that effectively address various lipid-related health issues.
Latest Patents
Junbo Wang's latest patents include groundbreaking technologies aimed at reducing lipid levels. One of his notable inventions involves compounds and compositions that comprise extracts or isolated compounds from plants. These innovations provide prevention and treatment for conditions such as hyperlipidemia, hypercholesterolemia, hypertriglyceridemia, hepatic steatosis, and metabolic syndrome. The compounds and their derivatives, both natural and synthetic, are designed to lower total cholesterol, LDL-cholesterol, and triglycerides while increasing hepatic LDL receptor expression and activating AMP-activated protein kinase. Specific stereoisomers of these compounds with lipid-lowering activity include 14R-(+)-corypalmine, 14R,13S-(+)-corydaline, 14R-(+)-tetrahydropalmatin, (+)-corlumidin, d-(+)-bicuculline, and (+)-egenine. Another patent focuses on compounds of specific formulas and methods for their use, which also aim to lower cholesterol levels and activate key metabolic pathways.
Career Highlights
Junbo Wang is currently associated with Cvi Pharmaceuticals Limited, where he continues to advance his research in lipid management. His work has garnered attention for its potential impact on public health, particularly in addressing metabolic disorders.
Collaborations
Junbo Wang collaborates with esteemed colleagues, including Haiyan Liu and Jingwen Liu, to further enhance the scope and application of his inventions. Their combined expertise contributes to the development of effective solutions for lipid-related health issues.
Conclusion
Junbo Wang's innovative contributions to lipid level reduction through his patented technologies highlight his commitment to improving health outcomes. His work continues to pave the way for advancements in the treatment of metabolic disorders.